EQUINOX NEPREMICNINE d.d. Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 12, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	113	101	94	90	-
Market Cap Growth	7.72%	7.44%	4.88%	-	-
Enterprise Value	123	109	99	96	-
Last Close Price	63.00	54.80	49.42	45.73	-
PE Ratio	86.67	94.50	108.24	125.98	-
PS Ratio	11.58	11.66	12.08	12.21	-
PB Ratio	3.17	2.66	2.36	2.17	-
P/OCF Ratio	16.03	15.90	16.49	10.82	-
EV/Sales Ratio	12.62	12.59	12.71	13.06	-
EV/EBITDA Ratio	23.91	25.71	23.97	19.93	-
EV/EBIT Ratio	102.53	348.46	269.49	68.35	-
Debt / Equity Ratio	0.29	0.22	0.22	0.35	0.35
Debt / EBITDA Ratio	2.03	1.93	2.15	3.03	3.60
Asset Turnover	0.19	0.17	0.14	0.13	-
Quick Ratio	0.66	0.98	3.15	1.78	5.39
Current Ratio	0.77	0.98	3.15	1.78	5.65
Return on Equity (ROE)	3.55%	2.75%	2.14%	1.75%	-
Return on Assets (ROA)	1.45%	0.37%	0.40%	1.52%	-
Return on Capital (ROIC)	1.62%	0.41%	0.44%	1.60%	-
Earnings Yield	1.15%	1.06%	0.92%	0.79%	-
Dividend Yield	2.90%	3.34%	3.42%	3.13%	-
Payout Ratio	244.16%	282.82%	295.15%	-	-
Buyback Yield / Dilution	1.56%	1.55%	-1.73%	-	-
Total Shareholder Return	4.47%	4.89%	1.70%	3.13%	-

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.